STAGE IIA GASTRIC CANCER AJCC V7

Clinical trials for STAGE IIA GASTRIC CANCER AJCC V7 explained in plain language.

Never miss a new study

Get alerted when new STAGE IIA GASTRIC CANCER AJCC V7 trials appear

Sign up with your email to follow new studies for STAGE IIA GASTRIC CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy trial aims to boost stomach cancer survival

Disease control Ongoing

This study is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation improves outcomes for people with operable stomach cancer. It focuses on two specific types: cancers with mismatch repair deficiency or Epstein-Barr virus positivity. …

Matched conditions: STAGE IIA GASTRIC CANCER AJCC V7

Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

STAGE IIA GASTRIC CANCER AJCC V7

Get alerted when new STAGE IIA GASTRIC CANCER AJCC V7 trials appear

New combo therapy trial aims to boost stomach cancer survival